Pharmaceutical preparations for human use for movement disorders, namely, chorea associated with Huntington's Disease

Pharmaceutical preparations for human use for movement disorders, namely, chorea associated with Huntington's Disease

Administration of a program for enabling patients to obtain discounts on prescription drug spending

Pharmaceutical preparations for human use for schizophrenia, adjunctive treatment of schizophrenia, schizoaffective disorder, bipolar disorder, bipolar mania, DiGeorge syndrome, Lesch-Nyhan syndrome, and movement disorders, namely, Myoclonus, Levodopa induced dyskinesia, dyskinetic cerebral palsy, dystonia, and tics

Pharmaceutical preparations for human use for schizophrenia, adjunctive treatment of schizophrenia, schizoaffective disorder, bipolar disorder, bipolar mania, DiGeorge syndrome, Lesch-Nyhan syndrome, and movement disorders, namely, Myoclonus, Levodopa induced dyskinesia, dyskinetic cerebral palsy, dystonia, and tics; Pharmaceutical preparations for the treatment of neurological, central nervous system, and movement diseases and disorders

providing medical information

Providing medical information

Providing medical information

Pharmaceutical preparations for human use for movement disorders, namely, tardive dyskinesia

Pharmaceutical preparations for human use for movement disorders, namely, tardive dyskinesia; Pharmaceutical preparations for the treatment of neurological, central nervous system, and movement diseases and disorders; Pharmaceutical preparations for the treatment of tardive dyskinesia

Pharmaceutical preparations for the treatment of neurological and psychiatric diseases and disorders, tardive dyskinesia, [ Tourette syndrome, ] dystonia, movement disorders, and tics